Dec 24, 2025: 6:05 a.m.:
U.S. caps Ozempic-style weight-loss drugs at $50/month for Medicare patients, slashing costs from $1,000
THE U.S. JUST CAPPED OZEMPIC-STYLE DRUGS AT $50 A MONTH – AND IT CHANGES EVERYTHING
The U.S. government is moving to cap weight-loss drugs like Wegovy and Zepbound at $50 per month for people on Medicare.
These are the same drugs that currently cost close to $1,000 a… pic.twitter.com/G9CgFznOAm
— Mario Nawfal (@MarioNawfal) December 24, 2025
